# Varenicline for Nicotine Dependence Among Those With HIV/AIDS

> **NCT01710137** · PHASE3 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 179 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo
- **BEHAVIORAL:** Smoking Cessation Counseling

## Key facts

- **NCT ID:** NCT01710137
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2019-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01710137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01710137, "Varenicline for Nicotine Dependence Among Those With HIV/AIDS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01710137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*